AMEY DZIULKO: Open Payments
NPI 1932114642 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 40 payments from 14 companies in 2025. Trend: 2023 $717 · 2024 $619 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $156 |
| E.R. Squibb & Sons, L.L.C. | 7 | $114 |
| Alnylam Pharmaceuticals Inc. | 5 | $92 |
| PFIZER INC. | 4 | $86 |
| Edwards Lifesciences Corporation | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Boston Scientific Corporation | 1 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $21 |
Products named: JARDIANCE, CAMZYOS, ONPATTRO, VYNDAQEL, WATCHMAN, WAINUA, LEQVIO, ELIQUIS.
Industry payments across NY — which companies pay providers there.
